(19)
(11) EP 4 584 251 A1

(12)

(43) Date of publication:
16.07.2025 Bulletin 2025/29

(21) Application number: 23767910.5

(22) Date of filing: 08.09.2023
(51) International Patent Classification (IPC): 
C07D 257/02(2006.01)
A61K 51/04(2006.01)
 C07F 5/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07D 257/02; A61K 49/106
(86) International application number:
PCT/EP2023/074771
(87) International publication number:
WO 2024/052549 (14.03.2024 Gazette 2024/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 09.09.2022 EP 22194915

(71) Applicant: Bayer Aktiengesellschaft
51373 Leverkusen (DE)

(72) Inventors:
  • BERGER, Markus
    12167 Berlin (DE)
  • BRUMBY, Thomas
    12163 Berlin (DE)
  • LOHRKE, Jessica
    12351 Berlin (DE)
  • HERBERT, Simon Anthony
    13467 Berlin (DE)
  • SÜLZLE, Detlev
    13465 Berlin (DE)
  • FRENZEL, Thomas
    85614 Kirchseeon (DE)
  • JOST, Gregor
    10318 Berlin (DE)
  • PIETSCH, Hubertus
    14532 Kleinmachnow (DE)

(74) Representative: BIP Patents 
c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 50
40789 Monheim am Rhein
40789 Monheim am Rhein (DE)

   


(54) NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING